Evidence map›Paper›PMID 30170857›Full record

ArticleThe Journal of pediatrics2018

Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care.

Rachel L Epstein, Vishakha Sabharwal, Elisha M Wachman, Kelley A Saia, Claudia Vellozzi, Susan Hariri, Benjamin P Linas

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06367465 (Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy), which is not on this map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06367465 recruitingnot on this mapstarted 2024, after this paper: background citation

Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy

TypeobservationalSponsorWashington University School of MedicineRan2024 to 2026Enrolled50ConditionsHepatitis C, Pregnancy ComplicationsArmsGlecaprevir-pibrentasvir
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children - United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  18. Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rachel L EpsteinDepartment of Pediatrics, Section of Infectious Diseases, Boston Medical Center, Boston, MA; Department of Internal Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA. Electronic address: rachel.epstein@bmc.org.
Vishakha SabharwalDepartment of Pediatrics, Section of Infectious Diseases, Boston Medical Center, Boston, MA.
Elisha M WachmanDepartment of Pediatrics, Division of Neonatology, Boston Medical Center, Boston, MA.
Kelley A SaiaDepartment of Obstetrics and Gynecology, Boston Medical Center, Boston, MA.
Claudia VellozziDivision of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Susan HaririDivision of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Benjamin P LinasDepartment of Internal Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA.
Boston Medical Center · USCenters for Disease Control and Prevention · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZACHARY Franklin MEISEL · 2015 to 2026
$20.7M
BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
Economic Modeling for HIV, Viral Hepatitis, STD, TB and School HealthU38PS004644 · PS · HARVARD SCHOOL OF PUBLIC HEALTH · PI SALOMON, JOSHUA A · 2014 to 2015
$2.9M
Simulation Modeling to Improve HIV/HCV Screening, Treatment and CareR01DA031059 · NIDA · BOSTON MEDICAL CENTER · PI LINAS, BENJAMIN P. · 2012 to 2015
$2.1M
NCATS NIH HHS UL1 TR001430NCHHSTP CDC HHS U38 PS004644NIAID NIH HHS P30 AI042853NIAID NIH HHS T32 AI052074NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA031059
6 · The paper itself

Abstract

objectivesThe US National Viral Hepatitis Action Plan calls for major efforts to expand hepatitis C virus (HCV) diagnosis and treatment; prenatal care settings are potential venues for expanding HCV testing. We aimed to characterize the HCV diagnostic cascade for women and infants and investigate factors associated with linkage and follow-up. STUDY

designWe used electronic health records for a 10-year cohort of 879 women with opioid use disorder from an obstetric clinic serving women with substance use disorders.

resultsAltogether, 744 women (85%) were screened for HCV; 510 (68%) were seropositive, of whom 369 (72%) had nucleic acid testing performed and of these 261 (71%) were viremic. Of 404 infants born to HCV-seropositive women, 273 (68%) were tested at least once for HCV, 180 (45%) completed the American Academy of Pediatrics-recommended perinatal HCV screening, and 5 (2.8%) were diagnosed with HCV infection and linked to care. More recent delivery date (2014-2015) was associated with maternal linkage to care (aOR, 2.5; 95% CI, 1.4-4.7). Maternal coinfection with HIV (aOR, 9.0; 95% CI, 1.1-72.8) and methadone maintenance therapy, compared with buprenorphine (aOR, 1.5; 95% CI, 0.9-2.5), were associated with higher rates of infant HCV testing.

conclusionsHCV prevalence among pregnant women with opioid use is high and infant HCV screening is imperfect. Programmatic changes to improve both mother and infant follow-up may help to bridge identified gaps in the cascade to cure.

Indexed as

Infectious Disease Transmission, VerticalNeonatal ScreeningAdultBostonCohort StudiesCoinfectionContinuity of Patient CareFemaleHepatitis CHIV InfectionsHumansInfant, NewbornOpiate Substitution TreatmentOpioid-Related DisordersPregnancyPregnancy Complications, Infectiouslinkage to carepediatric hepatitis Cprenatal screeningvertical transmission

Identifiers

PMID30170857
PMCPMC6252153
OpenAlexW2889095750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.